Intramuscular (IM) refers to administration of a substance directly into skeletal muscle tissue. This route of administration is commonly studied in peptide research as an alternative to subcutaneous (SC) and intravenous (IV) injection.

Key Points

  • Absorption Rate: Generally slower than IV and subcutaneous administration
  • Onset: Typically 30-60 minutes for many peptides
  • Duration: Often longer than SC administration due to sustained release from muscle tissue
  • Volume Limits: Typically 2-5 mL per injection site (greater capacity than SC)
  • Common Sites: Deltoid (upper arm), vastus lateralis (thigh), gluteus maximus (buttock)

Mechanism of Absorption

After intramuscular injection, the substance moves from muscle tissue into the systemic circulation through:

  • Capillary circulation: The primary pathway for most compounds
  • Lymphatic drainage: Contributes, particularly for larger molecules like peptides
  • Perfusion differences: Blood flow to the injection site affects absorption rate

The rate of absorption is influenced by muscle blood flow, with the deltoid generally having faster absorption than the gluteus.

Research Context

In peptide research, intramuscular administration is often studied because:

  • Higher volume capacity: Allows administration of larger volumes than SC
  • Sustained release profile: Muscle tissue can act as a depot, releasing peptide gradually
  • Different pharmacokinetics: IM administration produces distinct absorption profiles compared to SC and IV
  • Clinical parallels: Many peptide therapies are approved for IM administration

Comparison to Other Routes

RouteOnsetDurationVolume LimitBioavailability
IVImmediateShortestN/A~100%
SCModerateModerate1-2 mL50-80%
IMModerateLonger2-5 mL60-90%

Safety Considerations

  • Proper technique: Correct needle length and angle are essential to ensure delivery into muscle tissue
  • Site rotation: Helps prevent tissue damage and scar formation
  • Nerve avoidance: Knowledge of anatomy is critical to avoid nerve injury
  • Local reactions: Pain, inflammation, or nodules may occur at injection sites

Note: This term describes an administration route, not a recommendation. Always follow approved protocols and institutional guidelines for research procedures.